Detailed financial statements for Sonida Senior Living, Inc. (SNDA): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year with up to 20 years of history.
Sonida Senior Living, Inc. is a company dedicated to the senior housing sector within the United States, actively involved in the development, ownership, management, and operation of various communities. Their independent living options provide residents with a comprehensive suite of amenities, including daily meal service, scheduled transportation, social and recreational programs, laundry and housekeeping, and continuous on-site staff.
Analysis Summary
Sonida Senior Living, Inc. reported revenue of $381.1M in the most recent fiscal year, growing at a 5-year CAGR of -0.1%.
Trailing-twelve-month margins: gross margin -15.8%, operating margin -16.8%, net margin -23.3%.
At the current price of $39.43, SNDA has negative trailing earnings (P/E not meaningful) and an ROE of -26.06%. Market capitalisation stands at $1.9B.
Balance sheet quality for SNDA: current ratio of 0.7, net debt of $678.7M. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.4M | $467.0M | $460.0M | $447.1M | $383.9M | $234.7M | $238.4M | $255.3M | $304.3M | $381.1M |
| Cost of Revenue | $273.9M | $492.4M | $294.7M | $310.6M | $279.6M | $40.9M | $27.4M | $21.1M | $33.1M | $411.5M |
| Gross Profit | $173.5M | -$25.4M | $165.4M | $136.5M | $104.3M | $193.8M | $211.1M | $234.2M | $271.2M | -$30.4M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $97.0M | $90.5M | $91.9M | $87.0M | $57.7M | $32.3M | $30.3M | $32.2M | $40.0M | $39.9M |
| Operating Expenses | $159.2M | -$33.2M | $157.8M | $151.2M | $104.3M | $227.5M | $240.4M | $249.4M | $286.1M | $27.8M |
| Operating Income | $14.4M | $7.8M | $7.6M | -$14.7M | 0 | -$33.7M | -$29.3M | -$15.2M | -$14.8M | -$58.2M |
| EBITDA | $74.8M | $74.0M | $58.0M | $78.4M | -$190.1M | $201.3M | $17.2M | $55.2M | $78.0M | $23.2M |
| Interest Expense | $42.2M | $49.5M | $50.5M | $49.8M | $44.6M | $37.2M | $33.0M | $36.1M | $37.0M | $38.6M |
| Pre-tax Income | -$27.6M | -$41.7M | -$55.4M | -$35.6M | -$295.0M | $126.2M | -$54.3M | -$20.9M | -$3.0M | -$72.2M |
| Income Tax | $435000 | $2.5M | -$1.8M | $448000 | $389000 | $583000 | $86000 | $253000 | $239000 | $330000 |
| Net Income | -$28.0M | -$44.2M | -$53.6M | -$36.0M | -$295.4M | $125.6M | -$54.4M | -$21.1M | -$2.1M | -$70.8M |
| EPS | $-14.55 | $-22.50 | $-26.97 | $-16.72 | $-134.87 | $38.24 | $-9.27 | $-3.85 | $-0.54 | $-4.22 |
| EPS (Diluted) | $-14.54 | $-22.49 | $-26.97 | $-16.72 | $-134.87 | $37.92 | $-9.27 | $-3.85 | $-0.54 | $-4.22 |
| Shares Outstanding (Diluted) | $1.9M | $2.0M | $2.0M | $2.2M | $2.2M | $2.8M | $6.4M | $6.8M | $14.1M | $18.1M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34.0M | $17.6M | $31.3M | $24.0M | $17.9M | $78.7M | $16.9M | $4.1M | $17.0M | $11.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $13.7M | $12.3M | $10.6M | $8.1M | $5.8M | $4.0M | $6.1M | $8.0M | $19.0M | $18.6M |
| Inventory | $13.3M | $13.4M | $13.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $82.0M | $64.0M | $73.5M | $63.2M | $43.4M | $106.2M | $43.6M | $32.3M | $64.1M | $77.9M |
| Property, Plant & Equipment | $1.03B | $1.10B | $1.06B | $1.19B | $655.5M | $621.2M | $615.8M | $588.2M | $739.9M | $736.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $6.3M | $200000 | $700000 | $800000 | $800000 | 0 | 0 | $622000 | $24.5M | $19.7M |
| Total Assets | $1.15B | $1.18B | $1.15B | $1.27B | $702.8M | $728.6M | $661.3M | $621.5M | $841.9M | $844.8M |
| Accounts Payable | $5.1M | $7.8M | $9.1M | $10.4M | $15.0M | $9.2M | $7.3M | $11.4M | $9.0M | $4.7M |
| Short-term Debt | $17.9M | $22.8M | $14.3M | $15.8M | $304.2M | $69.8M | $46.0M | $42.3M | $15.5M | $7.3M |
| Total Current Liabilities | $81.4M | $87.0M | $85.0M | $129.0M | $373.1M | $120.5M | $94.3M | $100.9M | $75.6M | $105.1M |
| Long-term Debt | $882.5M | $938.2M | $959.4M | $905.6M | $604.7M | $613.3M | $625.0M | $587.1M | $635.9M | $682.5M |
| Total Liabilities | $1.03B | $1.10B | $1.11B | $1.25B | $982.1M | $734.1M | $719.4M | $688.0M | $712.3M | $788.6M |
| Retained Earnings | -$51.6M | -$95.9M | -$149.5M | -$172.9M | -$468.3M | -$342.7M | -$397.1M | -$418.2M | -$420.2M | -$491.0M |
| Total Equity | $116.9M | $80.4M | $35.3M | $14.4M | -$279.3M | -$5.6M | -$58.2M | -$66.5M | $123.0M | $51.2M |
| Total Debt | $939.2M | $1.01B | $1.02B | $1.19B | $909.8M | $683.7M | $671.0M | $629.4M | $651.4M | $689.7M |
| Net Debt | $905.1M | $992.2M | $991.2M | $1.16B | $892.0M | $605.0M | $654.1M | $625.3M | $634.4M | $678.7M |
| Working Capital | $638000 | -$23.0M | -$11.6M | -$65.8M | -$329.7M | -$14.3M | -$50.8M | -$68.5M | -$11.5M | -$27.3M |
Cash Flow (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$28.0M | -$44.2M | -$53.6M | -$36.0M | -$295.4M | $125.6M | -$54.4M | -$21.1M | -$3.3M | -$72.5M |
| Depreciation & Amortization | $60.4M | $66.2M | $62.8M | $64.2M | $60.3M | $37.9M | $38.4M | $39.9M | $44.1M | $56.8M |
| Stock-based Compensation | $11.6M | $7.7M | $8.4M | $2.5M | $1.7M | $2.8M | $4.3M | $2.7M | $4.4M | $5.0M |
| Change in Working Capital | -$1.8M | $3.8M | $3.4M | $1.9M | $10.6M | -$8.5M | $3.2M | $13.8M | -$7.2M | $12.9M |
| Operating Cash Flow | $52.3M | $55.6M | $36.9M | $5.2M | -$6.8M | -$28.8M | -$2.6M | $10.7M | -$1.8M | $24.4M |
| Capital Expenditure | -$62.4M | -$40.0M | -$22.0M | -$20.3M | -$15.6M | -$10.4M | -$24.6M | -$17.9M | -$25.2M | -$33.3M |
| Acquisitions | -$138.8M | -$85.0M | $57000 | $68.1M | 0 | 0 | -$12.3M | 0 | -$184.4M | -$37.4M |
| Stock Repurchased | -$2.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -$3.0M | 0 | -$2.8M | -$5.6M |
| Free Cash Flow | -$10.1M | $15.6M | $14.9M | -$15.1M | -$22.4M | -$39.2M | -$27.1M | -$7.3M | -$27.0M | -$8.9M |
Growth & Margins (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +4.4% | -1.5% | -2.8% | -14.1% | -38.9% | +1.6% | +7.1% | +19.2% | +25.2% | |
| Net Income Growth (YoY) | -57.6% | -21.3% | +32.8% | -719.8% | +142.5% | -143.3% | +61.2% | +90.2% | -3337.5% | |
| EPS Growth (YoY) | -54.6% | -19.9% | +38.0% | -706.6% | +128.4% | -124.2% | +58.5% | +86.0% | -681.5% | |
| Shares Change (YoY) | +1.9% | +1.2% | +8.4% | +1.6% | +26.6% | +129.3% | +6.7% | +107.9% | +28.2% | |
| FCF Growth (YoY) | +254.9% | -4.7% | -201.2% | -48.7% | -75.0% | +30.8% | +73.3% | -271.5% | +66.9% | |
| Gross Margin | 38.8% | -5.4% | 35.9% | 30.5% | 27.2% | 82.6% | 88.5% | 91.7% | 89.1% | -8.0% |
| Operating Margin | 3.2% | 1.7% | 1.7% | -3.3% | 0.0% | -14.3% | -12.3% | -5.9% | -4.9% | -15.3% |
| EBITDA Margin | 16.7% | 15.8% | 12.6% | 17.5% | -49.5% | 85.8% | 7.2% | 21.6% | 25.6% | 6.1% |
| Net Margin | -6.3% | -9.5% | -11.7% | -8.1% | -76.9% | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% |
| FCF Margin | -2.3% | 3.3% | 3.2% | -3.4% | -5.8% | -16.7% | -11.4% | -2.8% | -8.9% | -2.3% |
| Effective Tax Rate | -1.6% | -6.0% | 3.2% | -1.3% | -0.1% | 0.5% | -0.2% | -1.2% | -7.9% | -0.5% |
Per-Share Data (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF Per Share | $-5.24 | $7.96 | $7.50 | $-7.00 | $-10.24 | $-14.15 | $-4.27 | $-1.07 | $-1.91 | $-0.49 |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.20 | $0.31 |
| Shares Outstanding (Basic) | $1.9M | $2.0M | $2.0M | $2.2M | $2.2M | $2.8M | $6.4M | $6.8M | $14.1M | $18.1M |
What to look at in Healthcare / Pharma
The R&D pipeline is the invisible asset. Patents expiring = revenues evaporating. Look at innovation and cash flow.
- R&D / Revenue — Shows investment in future pipeline. Serious pharma reinvests 15-20%
- 5y EPS growth — After patent expirations, are they still growing?
- Gross margin — Branded pharma >70%. Generics much lower — defines the business type
- FCF / Net Income — Earnings quality — big pharma should convert >90%
- ROIC — Capital reinvested efficiently — key in pharma due to long R&D cycles
- Net debt / EBITDA — Pharma acquisitions pile up debt — watch the post-M&A picture
- P/E vs own 10y history — The best comparison is with its own history, not with peers
Profitability
| Return on Equity | -26.06% |
| Return on Invested Capital | -3.61% |
| Return on Assets | -4.80% |
| Gross Margin | -15.77% |
| Operating Margin | -16.76% |
| Net Margin | -23.27% |
Financial Health
| Debt / Equity | 1.83 |
| Current Ratio | 0.88 |
Key Ratios (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -16.55 | -8.99 | -3.78 | -2.77 | -0.09 | 0.75 | -1.35 | -2.51 | -42.74 | -7.73 |
| P/B | 3.97 | 4.94 | 5.75 | 6.95 | -0.10 | -14.09 | -1.37 | -0.99 | 2.65 | 11.51 |
| P/S | 1.04 | 0.85 | 0.44 | 0.22 | 0.07 | 0.33 | 0.33 | 0.26 | 1.07 | 1.55 |
| Gross Margin | 38.8% | -5.4% | 35.9% | 30.5% | 27.2% | 82.6% | 88.5% | 91.7% | 89.1% | -8.0% |
| Operating Margin | 3.2% | 1.7% | 1.7% | -3.3% | 0.0% | -14.3% | -12.3% | -5.9% | -4.9% | -15.3% |
| Net Margin | -6.3% | -9.5% | -11.7% | -8.1% | -76.9% | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% |
Related companies: ANGO · CMPS · CYH · EHAB · FULC · LAB · OCGN
Explore sector: Healthcare · Medical - Care Facilities
More sections of SNDA: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks